Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tullio Florio

Showing results (101-110 of 180) with videos related to

Pageof 18
Sort By:
Molecular Pharmacology|October 26, 2007
17beta-estradiol promotes breast cancer cell proliferation-inducing stromal cell-derived factor-1-mediated epidermal growth factor receptor transactivation: reversal by gefitinib pretreatmentAlessandra Pattarozzi, Monica Gatti, Federica Barbieri, et al.
Endocrine|August 3, 2016
Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumorsGermano Gaudenzi, Manuela Albertelli, Alessandra Dicitore, et al.
Frontiers in Endocrinology|May 8, 2023
Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials?Giuseppe Fanciulli, Roberta Modica, Anna La Salvia, et al.
Cancer Research|April 19, 2003
Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and AktSimone Barbero, Rudy Bonavia, Adriana Bajetto, et al.
Annals of the New York Academy of Sciences|March 27, 2007
Characterization of the proapoptotic intracellular mechanisms induced by a toxic conformer of the recombinant human prion protein fragment 90-231Valentina Villa, Alessandro Corsaro, Stefano Thellung, et al.
Journal of Clinical Medicine|January 1, 2021
Emerging Therapies in Pheochromocytoma and Paraganglioma: Immune Checkpoint Inhibitors in the Starting BlocksGiuseppe Fanciulli, Sergio Di Molfetta, Andrea Dotto, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 7, 2026
The PDE5 inhibitor vardenafil enhances glutamatergic transmission through amyloid-beta and cellular prion proteinMd Abdullah A Kafi, Mario Passalacqua, Viviana Villa, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 9, 2023
Development and validation of a GC-MS method for determination of metformin in normal brain and in glioblastoma tissuesGiorgia Ailuno, Sara Baldassari, Alice Balboni, et al.
Molecules (Basel, Switzerland)|November 13, 2020
Co-Administration of Fendiline Hydrochloride Enhances Chemotherapeutic Efficacy of Cisplatin in Neuroblastoma TreatmentAntonella Brizzolara, Patrizia Garbati, Serena Vella, et al.
Annals of the New York Academy of Sciences|December 18, 2002
Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitroSimone Barbero, Adriana Bajetto, Rudy Bonavia, et al.
Pageof 18

Showing results (101-110 of 180) with videos related to

Sort By:
Pageof 18
Molecular Pharmacology|October 26, 2007
17beta-estradiol promotes breast cancer cell proliferation-inducing stromal cell-derived factor-1-mediated epidermal growth factor receptor transactivation: reversal by gefitinib pretreatmentAlessandra Pattarozzi, Monica Gatti, Federica Barbieri, et al.
Endocrine|August 3, 2016
Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumorsGermano Gaudenzi, Manuela Albertelli, Alessandra Dicitore, et al.
Frontiers in Endocrinology|May 8, 2023
Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials?Giuseppe Fanciulli, Roberta Modica, Anna La Salvia, et al.
Cancer Research|April 19, 2003
Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and AktSimone Barbero, Rudy Bonavia, Adriana Bajetto, et al.
Annals of the New York Academy of Sciences|March 27, 2007
Characterization of the proapoptotic intracellular mechanisms induced by a toxic conformer of the recombinant human prion protein fragment 90-231Valentina Villa, Alessandro Corsaro, Stefano Thellung, et al.
Journal of Clinical Medicine|January 1, 2021
Emerging Therapies in Pheochromocytoma and Paraganglioma: Immune Checkpoint Inhibitors in the Starting BlocksGiuseppe Fanciulli, Sergio Di Molfetta, Andrea Dotto, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 7, 2026
The PDE5 inhibitor vardenafil enhances glutamatergic transmission through amyloid-beta and cellular prion proteinMd Abdullah A Kafi, Mario Passalacqua, Viviana Villa, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 9, 2023
Development and validation of a GC-MS method for determination of metformin in normal brain and in glioblastoma tissuesGiorgia Ailuno, Sara Baldassari, Alice Balboni, et al.
Molecules (Basel, Switzerland)|November 13, 2020
Co-Administration of Fendiline Hydrochloride Enhances Chemotherapeutic Efficacy of Cisplatin in Neuroblastoma TreatmentAntonella Brizzolara, Patrizia Garbati, Serena Vella, et al.
Annals of the New York Academy of Sciences|December 18, 2002
Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitroSimone Barbero, Adriana Bajetto, Rudy Bonavia, et al.
Pageof 18